SSA
South Street Advisors Portfolio holdings
AUM
$763M
1-Year Est. Return
37.04%
1 Year Est. Return
+37.04%
AUM
$763M
AUM Growth
+$88.8M
(+13%)
Holding
85
Top Buys
| 1 | +$9.88M | |
| 2 | +$2.78M | |
| 3 | +$1.67M | |
| 4 |
Microsoft
MSFT
|
+$1.66M |
| 5 |
Eli Lilly
LLY
|
+$1.61M |
Top Sells
| 1 | +$7.51M | |
| 2 | +$4.61M | |
| 3 | +$4.61M | |
| 4 |
Gold Fields
GFI
|
+$2.51M |
| 5 |
Novo Nordisk
NVO
|
+$2.15M |
Sector Composition
| 1 | Technology | 30.15% |
| 2 | Financials | 14.13% |
| 3 | Industrials | 11.49% |
| 4 | Consumer Discretionary | 11.24% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Novartis
NVS
$254B
| $244K | 0.03% |
+1,900
|
|
||
77
Merck
MRK
$250B
| $226K | 0.03% |
+2,687
|
|
||
78
Pultegroup
PHM
$24.9B
| $225K | 0.03% |
+1,700
|
|
||
79
NextEra Energy
NEE
$174B
| $211K | 0.03% |
+2,800
|
|
||
80
Fortinet
FTNT
$63.3B
| $210K | 0.03% |
+2,500
|
|
||
81
Rockwell Automation
ROK
$45.3B
| $210K | 0.03% |
+600
|
|
||
82
CRISPR Therapeutics
CRSP
$5.61B
| $208K | 0.03% |
+3,203
|
|
||
83
Colgate-Palmolive
CL
$62.6B
| – | – |
-2,600
|
|
||
84
Trane Technologies
TT
$89.9B
| – | – |
-465
|
|
||
85
XPO
XPO
$16.5B
| – | – |
-1,735
|
|